![John Gay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Gay
Geen lopende functies
Vermogen: 807 811 $ op 31-05-2026
Profiel
John M.
Gay is Chief Financial Officer, Secretary & Treasurer at Pelthos Therapeutics, Inc. since 2026.
Former positions include Director-SEC Reporting at Valassis Digital Corp.
and Maxpoint, Inc. from 2014 to 2018; Chief Financial & Accounting Officer & Secretary at NVN Liquidation, Inc. in 2023; Controller at Furiex Pharmaceuticals, Inc. from 2010 to 2014; Audit Senior Manager at Deloitte & Touche LLP and Arthur Andersen LLP from 2000 to 2010; and Chief Financial Officer at LNHC, Inc. Education includes undergraduate and graduate degrees from The University of North Carolina at Chapel Hill.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,88% | 10-04-2026 | 30.518 ( 0,88% ) | 807 811 $ | 31-05-2026 |
Actieve functies van John Gay
| Bedrijven | Functie | Begin |
|---|
Eerdere bekende functies van John Gay
| Bedrijven | Functie | Einde |
|---|---|---|
| NVN LIQUIDATION, INC. | Financieel Directeur/CFO | 26-09-2023 |
| MAXPOINT INTERACTIVE INC | Corporate Officer/Principal | 01-04-2018 |
Maxpoint, Inc.
 Maxpoint, Inc. Maxpoint, Inc. is a company based in Wylie. | Corporate Officer/Principal | 01-04-2018 |
| FURIEX PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 01-05-2014 |
Opleiding van John Gay
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
98
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
NVN Liquidation, Inc.
 NVN Liquidation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops treatment for nitric oxide’s immunomodulatory & anti microbial mechanisms | Health Technology |
Furiex Pharmaceuticals, Inc.
 Furiex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug development collaboration company | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valassis Digital Corp.
 Valassis Digital Corp. Advertising/Marketing ServicesCommercial Services Provides digital advertising and marketing automation software solutions | Commercial Services |
Maxpoint, Inc.
Maxpoint, Inc. Maxpoint, Inc. is a company based in Wylie. |
